These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4117276)

  • 21. Myasthenia gravis: how to treat?
    Tireli H; Karlikaya G; Tutkavul K; Akpinar A; Okay T
    Acta Myol; 2004 Dec; 23(3):140-5. PubMed ID: 15938570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological studies on myasthenia gravis: operative indication and cell-mediated immunity.
    Fukawa M; Torisu M; Miyahara T; Harasaki H; Kai S; Yamamoto H; Konomi K; Nishimura M; Tanaka J
    Surgery; 1978 Mar; 83(3):293-302. PubMed ID: 305125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunological effects of thymectomy in myasthenia gravis.
    Scadding GK; Thomas HC; Havard CW
    Clin Exp Immunol; 1979 May; 36(2):205-13. PubMed ID: 314366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppressive treatment with azathioprine and antilymphocyte serum in myasthenia].
    Benelli L; Tacconi G; Casacchia M; Paolella P; Agnoli A
    Riv Neurobiol; 1974; 20(14):87-105. PubMed ID: 4471382
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of immunosuppression on the development of immunity to fowl typhoid.
    Cameron CM; Brett OL; Fuls WJ
    Onderstepoort J Vet Res; 1974 Mar; 41(1):15-21. PubMed ID: 4213431
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
    Fasola CG; Hricik DE; Schulak JA
    Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of anti-thymocyte antiserum in progressive myasthenia gravis.
    Pirofsky B
    Ann N Y Acad Sci; 1981; 377():779-85. PubMed ID: 6978666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract]   [Full Text] [Related]  

  • 33. Myasthenia gravis: ALG treatment of seriously ill patients.
    Leövey A; Szobor A; Szegedi Gy; Szathmáry I; Petrányi Gy
    Eur Neurol; 1975; 13(5):422-32. PubMed ID: 1080463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppressive treatment in neurological disorders].
    Aarli JA
    Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effect of adult thymectomy in mice treated with antilymphocyte or antithymocyte serum.
    Wood ML; Monaco AP
    Transplantation; 1972 Dec; 14(6):807-10. PubMed ID: 4566277
    [No Abstract]   [Full Text] [Related]  

  • 36. The complement system in renal homograft recipents.
    Yokoyama T; Torisu M; Durst AL; Schroter G; Groth CG; Starzl TE
    Surgery; 1972 Oct; 72(4):611-8. PubMed ID: 4560540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 38. AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS.
    ADNER MM; SHERMAN JD; ISE C; SCHWAB RS; DAMESHEK W
    N Engl J Med; 1964 Dec; 271():1327-33. PubMed ID: 14214644
    [No Abstract]   [Full Text] [Related]  

  • 39. [Post-thymectomy changes of factors in the blood in myasthenia gravis].
    Shimabukuro K; Yoshida T; Tsuchiya M
    Nihon Rinsho; 1973 Feb; 31(2):291-9. PubMed ID: 4124249
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thymectomy in myasthenia gravis].
    Schumpelick V; Janzen RW
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1166-72. PubMed ID: 6086265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.